Clinical trials: Panic Disorder
- Condition Panic Disorder
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Anxiety, Fear
A Randomized Controlled Test of the Effects of CHI-554 on Fear.
This is a randomized, double-blind, placebo-controlled phase 2b clinical trial examining the effects of CHI-554 (CBD) on Fear (F-01)
- Conditions
- Anxiety, Fear, Panic
- Trial name
- NCT04577612
- Testing
- CHI-554
- Where
- United States
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Canopy Growth Corporation
Panic Disorder
A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects
The purpose of this study is to determine anxiolytic effect of multiple doses of CVL-865 using an experimental medicine model of carbon dioxide (CO2) inhalation in healthy volunteers.
- Trial name
- NCT04592536
- Testing
- CVL-865 High dose, Alprazolam 1mg XR, CVL-865 low dose
- Where
- Netherlands
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Cerevel Therapeutics, LLC
Healthy Subjects
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
Study to evaluate if Xanax sustained release tablets manufactured at two different sites provide similar drug levels in the blood.
- Trial name
- NCT01330472
- Testing
- Xanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta)
- Where
- Singapore
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.